Roger B. Lee

Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunohistochemical Expression: A Gynecologic Oncology Group Study

Russell J. Schilder, Michael W. Sill, Xiaowei Chen et al. · Clinical Cancer Research · 2005 · 259 citations · Full text

Medicine, Oncology, Pharmacology +17

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Peter G. Rose, Virginia L. Brunetto, Linda Vanle et al. · Gynecologic Oncology · 2000 · 201 citations

Medicine, Gynecology, Oncology +8

Estrogen replacement therapy following treatment for stage I endometrial carcinoma

Roger B. Lee, Thomas W. Burke, Robert C. Park · Gynecologic Oncology · 1990 · 176 citations

Medicine, Gynecology, Oncology +11

Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study

Sarah T. Lincoln, John A. Blessing, Roger B. Lee et al. · Gynecologic Oncology · 2003 · 173 citations

Medicine, Oncology, Pharmacology +10

Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

Russell J. Schilder, Michael W. Sill, Roger B. Lee et al. · Journal of Clinical Oncology · 2008 · 111 citations · Full text

Medicine, Oncology, Pharmacotherapy +16